These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16596500)

  • 1. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--Against].
    Ertl G; Bauer W
    Dtsch Med Wochenschr; 2006 Apr; 131(14):773. PubMed ID: 16596500
    [No Abstract]   [Full Text] [Related]  

  • 2. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--For].
    Klein HU
    Dtsch Med Wochenschr; 2006 Apr; 131(14):772. PubMed ID: 16596499
    [No Abstract]   [Full Text] [Related]  

  • 4. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy for heart failure.
    Abraham WT; Hayes DL
    Circulation; 2003 Nov; 108(21):2596-603. PubMed ID: 14638522
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontiers in congestive heart failure: initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Tepper D
    Congest Heart Fail; 2002; 8(2):91. PubMed ID: 11927784
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias.
    Kiès P; Bax JJ; Molhoek SG; Bleeker GB; Zeppenfeld K; Bootsma M; St John Sutton M; van Erven L; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Jul; 94(1):130-2. PubMed ID: 15219525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
    Botto GL; Luzi M; Russo G; Mariconti B
    G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
    [No Abstract]   [Full Text] [Related]  

  • 15. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely.
    Cleland JG; Tageldien A; Maarouf N; Hobson N
    Heart; 2008 Aug; 94(8):963-6. PubMed ID: 18625785
    [No Abstract]   [Full Text] [Related]  

  • 17. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Vos DH; Elvan A; Ramdat Misier AR; Beukema WP; Steendijk P; van Hemel NM
    Eur Heart J; 2009 Apr; 30(7):797-804. PubMed ID: 19202156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.